Mercury Systems (MRCY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 May, 2026Executive summary
Q3 FY26 delivered record bookings of $348.3M, a book-to-bill ratio of 1.48, and backlog nearing $1.6B, reflecting robust organic growth and margin expansion year-over-year.
Revenue reached $235.8M, up 11.5% organically year-over-year, with adjusted EBITDA of $36.1M (15.3% margin), up 46% year-over-year.
Domestic revenue, comprising 88% of Q3 revenue, grew 17% year-over-year, driven by strong demand across missile, C4I, and space programs.
GAAP net loss narrowed to $2.9M ($0.04/share) from $19M ($0.33/share) year-over-year.
Free cash outflow was $2M, with cash and equivalents at quarter-end of $332M.
Financial highlights
Q3 bookings reached $348.3M, up 74% year-over-year; backlog up 18% to $1.6B.
Gross margin improved by 230 bps to 29.3% year-over-year.
Adjusted EPS rose to $0.27 from $0.06 year-over-year.
Adjusted EBITDA was $36M, up 46% year-over-year; adjusted EBITDA margin expanded to 15.3%, up 360 bps.
Free cash flow was negative $2M for the quarter, compared to $24M in Q3 FY25.
Outlook and guidance
FY26 revenue growth outlook raised to approach mid-single digits (from low single digits); full-year adjusted EBITDA margin expected in the mid-teens.
Q4 bookings pipeline is more robust than Q3, with potential for strongest quarter of the year.
Free cash flow expected to be positive in Q4 and for the full year.
Approximately 50% of $859.8M in remaining performance obligations expected to be recognized as revenue in the next 12 months.
Management expects sufficient liquidity for at least the next twelve months.
Latest events from Mercury Systems
- Record backlog and strong cash flow highlight momentum and growth in defense technology.MRCY
Investor presentation - Record backlog and margin expansion drive Q2 growth, improved profitability, and strong outlook.MRCY
Q2 2026 - Director elections, executive pay, new incentive plan, and auditor ratification headline the agenda.MRCY
Proxy Filing - Board recommends approval of all proposals, with enhanced focus on pay-for-performance and ESG.MRCY
Proxy Filing - Record bookings, margin expansion, and strong free cash flow set the stage for FY26 growth.MRCY
Q4 2025 - Revenue up 13%, bookings up 29%, record backlog, and improved margins with positive outlook.MRCY
Q1 2025 - Record backlog and free cash flow support margin expansion and growth in FY25.MRCY
Q4 2024 - Revenue, adjusted EBITDA, and free cash flow all improved year-over-year in Q3 FY25.MRCY
Q3 2025 - Q2 FY25 saw 13% revenue growth, record free cash flow, and improved margins.MRCY
Q2 2025